Shots:
- Salipro to receive an up front, research payments and is eligible for a downstream milestones for several targets
- The collaboration will allow AbCellera to access Salipro Biotech’s expertise and its platform to produce stable Ag of membrane protein drug targets in drug discovery programs for therapeutic Abs
- Salipro Biotech has signed multiple research collaborations with pharma and biotech companies. Salipro will be responsible to accelerates the novel drugs discovery
Click here to read full press release/ article | Ref: PR Newswire | Image: PR Newswire
The post AbCellera Enters into a Collaboration and License Agreement with Salipro to Boost Therapeutic Antibodies first appeared on PharmaShots.
